Ligand Pharmaceuticals Inc (LGND)
114.58
+0.64
(+0.56%)
USD |
NASDAQ |
Dec 20, 16:00
115.00
+0.42
(+0.37%)
After-Hours: 20:00
Ligand Pharmaceuticals Market Cap: 2.165B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cellectar Biosciences Inc | 9.698M |
| Revance Therapeutics Inc | 323.10M |
| Pieris Pharmaceuticals Inc | -- |
| Zymeworks Inc | 973.93M |
| CNS Pharmaceuticals Inc | 6.381M |
Market Cap Related Metrics
| PE Ratio | 45.65 |
| PS Ratio | 13.58 |
| PEG Ratio | 0.2255 |
| Price to Book Value | 2.574 |
| Price to Free Cash Flow | 296.99 |
| Price | 114.58 |
| Earnings Yield | 2.19% |
| PEGY Ratio | 0.2255 |
| Operating PE Ratio | 115.12 |